𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Hepatitis C virus reinfection in liver transplant patients: Evaluation of liver damage progression with echo-color doppler

✍ Scribed by Massimo Bolognesi; Cristina Quaglio; Giancarlo Bombonato; Maria Guido; Luisa Cavalletto; Liliana Chemello; Carlo Merkel; Massimo Rugge; Angelo Gatta; David Sacerdoti


Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
322 KB
Volume
14
Category
Article
ISSN
1527-6465

No coin nor oath required. For personal study only.

✦ Synopsis


Liver transplant recipients are a model of rapid progression of hepatitis C virus (HCV)-related liver disease, from normal to cirrhosis. The aim of the study was the analysis of the relationship between portohepatic hemodynamics and modification in liver histology during the progression of HCV liver disease after transplant. Patients transplanted for HCV cirrhosis were considered for the study. At least every 6-12 months, the portal blood flow velocity, hepatic and splenic pulsatility indices, and a portal hypertensive index (obtained from the combination of the portal blood velocity and splenic pulsatility index) were measured with echo-Doppler. Liver biopsy was performed whenever necessary. The time course of echo-Doppler parameters during the histological progression of the liver disease was analyzed. Posttransplant patients without HCV were included as controls. Forty-nine patients with histology-proven relapse of HCV hepatitis were included in the study. At the onset of recurrent hepatitis, the portal blood flow velocity significantly decreased (P Ο½ 0.001), and the splenic pulsatility index increased (P Ο­ 0.020), whereas the hepatic pulsatility index remained unchanged. In the following years, in addition to a further slight decrease in the portal blood velocity (P Ο­ 0.027), a progressive increase in the hepatic and splenic pulsatility indices was also detected (P Ο­ 0.009 and P Ο½ 0.0001, respectively). The portal hypertensive index steadily increased with the progression of the disease and was related to the degree of liver fibrosis. In conclusion, the information obtainable from splanchnic Doppler parameters can be used to monitor the progression of liver fibrosis in transplant patients with HCV reinfection.


πŸ“œ SIMILAR VOLUMES


A prospective evaluation of fibrosis pro
✍ Nevin Yilmaz; Mitchell L. Shiffman; R. Todd Stravitz; Richard K. Sterling; Velim πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 186 KB πŸ‘ 2 views

Recurrence of hepatitis C virus (HCV) following liver transplantation (LT) is universal. A subset of these patients develop advanced fibrosis and cirrhosis and it is believed that this leads to increased posttransplantation mortality. The specific aims of this study were to determine the incidence o

Evolution of hepatitis C virus quasispec
✍ Mario G. Pessoa; Natalie Bzowej; Marina Berenguer; Yume Phung; Michael Kim; Lind πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 213 KB πŸ‘ 2 views

Evolution of hepatitis C quasispecies may be one mechanism by which fibrosing cholestatic hepatitis develops after liver transplantation. In this study, we compared changes in quasispecies complexity and/or divergence in (1) hepatitis C-infected immunosuppressed transplant recipients and in immunoco

Spontaneous clearance of hepatitis C vir
✍ Vishal Bhagat; Julie A. Foont; Eugene R. Schiff; Arie Regev πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 95 KB πŸ‘ 2 views

Spontaneous resolution of chronic hepatitis C virus (HCV) infection is exceedingly rare and poorly understood. As HCV and human immunodeficiency virus (HIV) have shared routes of transmission, HCV coinfection is estimated to affect 15%-30% of the HIV-positive population. We report 2 patients with HC

Survival and recurrence of hepatitis C a
✍ Jean-Charles Duclos-VallΓ©e; Cyrille FΓ©ray; MylΓ¨ne Sebagh; Elina Teicher; Anne-Ma πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 285 KB πŸ‘ 2 views

Liver transplantation in patients coinfected with human immunodeficiency virus (HIV) and hepatitis C virus (HCV) is a recent indication. In a single center, we have compared the survival and severity of recurrent HCV infection after liver transplantation in HIV-HCV-coinfected and HCV-monoinfected pa

Mutational pattern of hepatitis B virus
✍ Hans L. Tillmann; Christian Trautwein; Thomas Bock; Klaus H. BΓΆker; Elmar JΓ€ckel πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 197 KB πŸ‘ 2 views

## Famciclovir (FCV) and lamivudine (LAM) reduce viral replication in patients with recurrent hepatitis B virus (HBV) infection after orthotopic liver transplantation (OLT). Eighteen of 20 patients with insufficient response to FCV were treated with 100 mg LAM daily after OLT. These patients had s

Impact of donor age on survival and fibr
✍ Asma Poonawala Khapra; Kaushik Agarwal; Maria Isabel Fiel; Nickolas Kontorinis; πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 322 KB πŸ‘ 1 views

Studies have suggested that the use of hepatitis C virus (HCV)-positive (HCV+) donor allografts has no impact on survival. However, no studies have examined the effect that HCV+ donor histology has upon recipient and graft survival. We evaluated the clinical outcome and impact of histological featur